Respiratory Drug Market Report

Global and Region Respiratory Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：171
  • REPORT CODE：GMM1013496
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Respiratory Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Respiratory Drugmarket, defines the market attractiveness level of Respiratory Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Respiratory Drug industry, describes the types of Respiratory Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Respiratory Drug market and the development prospects and opportunities of Respiratory Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Respiratory Drug market in Chapter 13.

    By Player:

    • Sunovion

    • AstraZeneca

    • Novartis

    • Beximco Pharmaceuticals

    • Draeger

    • Merck

    • Baxter

    • Aradigm

    • Roche

    • GSK

    • Fisher & Paykel Healthcare

    • Air Liquide

    • Pfizer

    • Boehringer Ingelheim

    • Hamilton Medical

    • Omron

    • Genentech

    • Compumedics

    • GE Healthcare

    • Grifols

    By Type:

    • Advair

    • Symbicort turbuhaler

    • Spiriva

    • Xolair

    • Ventolin

    • Pulmicort

    • Orkambi

    • Relvar/breo ellipta

    • Singulair

    • Esbriet

    By End-User:

    • Hospitals

    • Home care

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Respiratory Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Respiratory Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Respiratory Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Respiratory Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Respiratory Drug Market Analysis and Outlook to 2022

    • 7.1 Global Respiratory Drug Consumption (2017-2022)

    • 7.2 United States Respiratory Drug Consumption (2017-2022)

    • 7.3 Europe Respiratory Drug Consumption (2017-2022)

    • 7.4 China Respiratory Drug Consumption (2017-2022)

    • 7.5 Japan Respiratory Drug Consumption (2017-2022)

    • 7.6 India Respiratory Drug Consumption (2017-2022)

    • 7.7 South Korea Respiratory Drug Consumption (2017-2022)

    8 Region and Country-wise Respiratory Drug Market Analysis and Outlook to 2028

    • 8.1 Global Respiratory Drug Consumption Forecast (2022-2028)

    • 8.2 United States Respiratory Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Respiratory Drug Consumption Forecast (2022-2028)

    • 8.4 China Respiratory Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Respiratory Drug Consumption Forecast (2022-2028)

    • 8.6 India Respiratory Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Respiratory Drug Consumption Forecast (2022-2028)

    9 Global Respiratory Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Respiratory Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Advair Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Symbicort turbuhaler Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Spiriva Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Xolair Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Ventolin Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Pulmicort Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Orkambi Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Relvar/breo ellipta Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Singulair Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Esbriet Consumption and Growth Rate (2017-2022)

    • 9.2 Global Respiratory Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Home care Consumption and Growth Rate (2017-2022)

    10 Global Respiratory Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Respiratory Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Advair Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Symbicort turbuhaler Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Spiriva Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Xolair Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Ventolin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Pulmicort Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Orkambi Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Relvar/breo ellipta Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Singulair Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global Esbriet Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Respiratory Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Home care Consumption Forecast and Growth Rate (2022-2028)

    11 Global Respiratory Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Respiratory Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Respiratory Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Respiratory Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Respiratory Drug Market Competitive Analysis

    • 14.1 Sunovion

      • 14.1.1 Sunovion Company Details

      • 14.1.2 Sunovion Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sunovion Respiratory Drug Product and Service

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Details

      • 14.2.2 AstraZeneca Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca Respiratory Drug Product and Service

    • 14.3 Novartis

      • 14.3.1 Novartis Company Details

      • 14.3.2 Novartis Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis Respiratory Drug Product and Service

    • 14.4 Beximco Pharmaceuticals

      • 14.4.1 Beximco Pharmaceuticals Company Details

      • 14.4.2 Beximco Pharmaceuticals Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Beximco Pharmaceuticals Respiratory Drug Product and Service

    • 14.5 Draeger

      • 14.5.1 Draeger Company Details

      • 14.5.2 Draeger Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Draeger Respiratory Drug Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Respiratory Drug Product and Service

    • 14.7 Baxter

      • 14.7.1 Baxter Company Details

      • 14.7.2 Baxter Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Baxter Respiratory Drug Product and Service

    • 14.8 Aradigm

      • 14.8.1 Aradigm Company Details

      • 14.8.2 Aradigm Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Aradigm Respiratory Drug Product and Service

    • 14.9 Roche

      • 14.9.1 Roche Company Details

      • 14.9.2 Roche Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Roche Respiratory Drug Product and Service

    • 14.10 GSK

      • 14.10.1 GSK Company Details

      • 14.10.2 GSK Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 GSK Respiratory Drug Product and Service

    • 14.11 Fisher & Paykel Healthcare

      • 14.11.1 Fisher & Paykel Healthcare Company Details

      • 14.11.2 Fisher & Paykel Healthcare Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Fisher & Paykel Healthcare Respiratory Drug Product and Service

    • 14.12 Air Liquide

      • 14.12.1 Air Liquide Company Details

      • 14.12.2 Air Liquide Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Air Liquide Respiratory Drug Product and Service

    • 14.13 Pfizer

      • 14.13.1 Pfizer Company Details

      • 14.13.2 Pfizer Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Pfizer Respiratory Drug Product and Service

    • 14.14 Boehringer Ingelheim

      • 14.14.1 Boehringer Ingelheim Company Details

      • 14.14.2 Boehringer Ingelheim Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Boehringer Ingelheim Respiratory Drug Product and Service

    • 14.15 Hamilton Medical

      • 14.15.1 Hamilton Medical Company Details

      • 14.15.2 Hamilton Medical Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Hamilton Medical Respiratory Drug Product and Service

    • 14.16 Omron

      • 14.16.1 Omron Company Details

      • 14.16.2 Omron Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Omron Respiratory Drug Product and Service

    • 14.17 Genentech

      • 14.17.1 Genentech Company Details

      • 14.17.2 Genentech Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Genentech Respiratory Drug Product and Service

    • 14.18 Compumedics

      • 14.18.1 Compumedics Company Details

      • 14.18.2 Compumedics Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Compumedics Respiratory Drug Product and Service

    • 14.19 GE Healthcare

      • 14.19.1 GE Healthcare Company Details

      • 14.19.2 GE Healthcare Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 GE Healthcare Respiratory Drug Product and Service

    • 14.20 Grifols

      • 14.20.1 Grifols Company Details

      • 14.20.2 Grifols Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Grifols Respiratory Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Respiratory Drug

    • Figure Respiratory Drug Picture

    • Table Global Respiratory Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Respiratory Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Respiratory Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Respiratory Drug Consumption by Country (2017-2022)

    • Figure United States Respiratory Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Respiratory Drug Consumption and Growth Rate (2017-2022)

    • Figure China Respiratory Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Respiratory Drug Consumption and Growth Rate (2017-2022)

    • Figure India Respiratory Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Respiratory Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Respiratory Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Respiratory Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Respiratory Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Respiratory Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Respiratory Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Respiratory Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Advair Consumption and Growth Rate (2017-2022)

    • Figure Global Symbicort turbuhaler Consumption and Growth Rate (2017-2022)

    • Figure Global Spiriva Consumption and Growth Rate (2017-2022)

    • Figure Global Xolair Consumption and Growth Rate (2017-2022)

    • Figure Global Ventolin Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmicort Consumption and Growth Rate (2017-2022)

    • Figure Global Orkambi Consumption and Growth Rate (2017-2022)

    • Figure Global Relvar/breo ellipta Consumption and Growth Rate (2017-2022)

    • Figure Global Singulair Consumption and Growth Rate (2017-2022)

    • Figure Global Esbriet Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Home care Consumption and Growth Rate (2017-2022)

    • Figure Global Advair Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Symbicort turbuhaler Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Spiriva Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Xolair Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ventolin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmicort Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orkambi Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Relvar/breo ellipta Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Singulair Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Esbriet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home care Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Respiratory Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Respiratory Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Sunovion (Foundation Year, Company Profile and etc.)

    • Table Sunovion Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sunovion Respiratory Drug Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Respiratory Drug Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Respiratory Drug Product and Service

    • Table Beximco Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Beximco Pharmaceuticals Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beximco Pharmaceuticals Respiratory Drug Product and Service

    • Table Draeger (Foundation Year, Company Profile and etc.)

    • Table Draeger Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Draeger Respiratory Drug Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Respiratory Drug Product and Service

    • Table Baxter (Foundation Year, Company Profile and etc.)

    • Table Baxter Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Respiratory Drug Product and Service

    • Table Aradigm (Foundation Year, Company Profile and etc.)

    • Table Aradigm Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aradigm Respiratory Drug Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Respiratory Drug Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Respiratory Drug Product and Service

    • Table Fisher & Paykel Healthcare (Foundation Year, Company Profile and etc.)

    • Table Fisher & Paykel Healthcare Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fisher & Paykel Healthcare Respiratory Drug Product and Service

    • Table Air Liquide (Foundation Year, Company Profile and etc.)

    • Table Air Liquide Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Air Liquide Respiratory Drug Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Respiratory Drug Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Respiratory Drug Product and Service

    • Table Hamilton Medical (Foundation Year, Company Profile and etc.)

    • Table Hamilton Medical Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hamilton Medical Respiratory Drug Product and Service

    • Table Omron (Foundation Year, Company Profile and etc.)

    • Table Omron Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omron Respiratory Drug Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Respiratory Drug Product and Service

    • Table Compumedics (Foundation Year, Company Profile and etc.)

    • Table Compumedics Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Compumedics Respiratory Drug Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Respiratory Drug Product and Service

    • Table Grifols (Foundation Year, Company Profile and etc.)

    • Table Grifols Respiratory Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols Respiratory Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US